Enanta Pharmaceuticals(DE:9EP)
€10.40+0.50 (+5.05%)
DE:9EP
Enanta Pharmaceuticals earnings date
€10.40
At close:+0.50 (+5.05%)
Enanta Pharmaceuticals (9EP) Q2 2026 Earnings Report
0 Followers
DE:9EP Q2 2026 EPS Results
- Actual EPS
- -EUR 0.41
- Consensus EPS
- -EUR 0.44
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.96
DE:9EP Q2 2026 Revenue Results
- Actual Revenue
- EUR 15.51M
- Expected Revenue
- EUR 15.39M
- Beat/Miss
- Beat by +EUR 119.32K
- YoY Revenue Growth
- +14.96%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 05/11/2026
- Time
- After Close
- Conference Call
- Monday, May 11, 2026
DE:9EP Upcoming Earnings
Enanta Pharmaceuticals's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:9EP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q4) | -0.65- | -0.79 | ― | ― |
| Aug 10, 2026 | 2026 (Q3) | -0.46-0.61 | -0.77 | 21.18% (+0.16) | |
| May 11, 2026 | 2026 (Q2) | -0.44-0.41 | -0.96 | 57.55% (+0.55) | |
| Feb 09, 2026 | 2026 (Q1) | -0.69-0.38 | -0.95 | 60.00% (+0.57) | |
| Nov 17, 2025 | 2025 (Q4) | -0.92-0.79 | -1.23 | 36.03% (+0.44) | |
| Aug 11, 2025 | 2025 (Q3) | -0.81-0.77 | -0.97 | 20.56% (+0.20) | |
| May 12, 2025 | 2025 (Q2) | -1.04-0.96 | -1.33 | 27.89% (+0.37) | |
| Feb 10, 2025 | 2025 (Q1) | -1.22-0.95 | -1.43 | 33.54% (+0.48) | |
| Nov 25, 2024 | 2024 (Q4) | -1.05-1.23 | -1.2 | -2.26% (-0.03) | |
| Aug 05, 2024 | 2024 (Q3) | -1.29-0.97 | -1.68 | 42.47% (+0.71) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
